Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ideal Medical Products accepts buyout deal

This article was originally published in The Gray Sheet

Executive Summary

Private equity fund HealthpointCapital acquires Paris-based Ideal Medical Products, the principal shareholder of spinal implant developer Scient'X. The two-step deal calls for the payment of $62 million to acquire the privately held Ideal Medical shares controlled by the Carli family, followed by initiation of a tender offer for the publicly held, minority interest in the company at $31.81 per share. Spinal fusion device maker Alphatec had sought to buy Scient'X in 2006 for $180 million, but the deal was later scuttled in favor of a licensing deal for Scient'X flagship dynamic stabilization product portfolio. HealthpointCapital, which also is Alphatec's principal stockholder, notes that this deal "will allow our firm to directly invest in and grow Scient'X" (1"The Gray Sheet" Jan. 29, 2007, p. 15)
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT025553

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel